PDMR Acquisition of Shares

Summary by AI BETAClose X

On February 23, 2026, James Halstead plc announced that Michael James Halstead, a Non-Executive Director and PDMR, transferred 52,000 ordinary shares from his nominee account on February 20, 2026, at a price of £1.3600 per share. Following this transfer, Michael James Halstead received 19,250 shares into his personal ISA, while Maria Halstead and Katherine Claire Halstead, both persons closely associated with him, received 18,045 and 14,705 shares respectively into their personal ISAs, also at £1.3600 per share.

Disclaimer*

James Halstead PLC
23 February 2026
 

23 February 2026

 

James Halstead plc

("James Halstead" or the "Company")

 

PDMR Acquisition of Shares

 

James Halstead plc (AIM: JHD) announces that on 23 February 2026, Michael James Halstead, a Non-Executive Director and PDMR of the Company, informed the Company that on the 20 February 2026; (1) Michael James Halstead had transferred 52,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares") from his nominee account.(2) Michael James Halstead received 19,250 Ordinary Shares into a personal ISA (3) Maria Halstead (PCA to Michael James Halsted) received 18,045 Ordinary Shares into a personal ISA (4) Katherine Claire Halstead (PCA to Michael James Halsted) received 14,705 Ordinary Shares into a personal ISA.  

The information below is set out in accordance with the requirements of the Market Abuse Regulation (EU) 596/2014 (which forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018, as amended), provides further details of the transaction EU Market Abuse Regulation, provides further detail on the transactions.

 1

Details of the person discharging managerial responsibilities / person closely associated 

a)

Name

(1)  Mr Michael James Halstead

(2)  Mr Micheal James Halstead

(3)  Mrs Maria Halstead

(4)  Ms Katherine Claire Halstead

2

Reason for the notification

a) 

Position/status 

(1)   Non-Executive Director

(2)   Non-Executive Director

(3)   PCA to Michael James Halstead

(4)   PCA to Michael James Halstead

b)

 

Initial notification /Amendment 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

James Halstead plc

b)

LEI

213800C8FFBYVO6UL498

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Identification code 

Ordinary Shares of 5p each

 

GB00B0LS8535

 

b)

Nature of the transaction

(1)  Transfer of 52,000 ordinary shares of 5p each from Michael James Halstead's nominee account.

(2)  Receive 19,250 ordinary shares of 5p each into Michael James Halstead's personal ISA. 

(3)  Receive 18,045 ordinary shares of 5p each into Maria Halstead's personal ISA

(4)  Receive 14,705 ordinary shares of 5p each into Katherine Claire Halstead's personal ISA

c)

 

Price(s) and volume(s)

 

 Prices per share

Volume(s)

1. £1.3600

2. £1.3600

3. £1.3600

4. £1.3600

52,000

19,250

18,450

14,705

 

d)

Aggregated information

- Aggregated volume

- Price

  

    52,000

    £1.3600

 

e)

Date of the transaction

20 February 2026

 

f)

Place of the transaction

London Stock Exchange - AIM

 

For further information please contact:

 

James Halstead plc:

David Fletcher, Company Secretary

Telephone 0161 767 2500

 


Hudson Sandler:

Nick Lyon / Nick Moore

Telephone: 020 7796 4133

 


Panmure Liberum (Nomad & Joint Broker):

Ed Mansfield / Tom Scrivens

Telephone: 020 7886 2500

 


Zeus (Joint Broker):

Ben Thorne / Fraser Marshall

 

Telephone: 020 3829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings